Cystatin C directly protects neurons against excitotoxicity through LRP2 (megalin) receptor engagement and AKT/ERK survival signaling. Critical weaknesses: neuronal LRP2 expression is technically challenging to detect and primarily studied in developmental contexts; systemic cystatin C must cross both BBB and neuronal membrane to engage LRP2—a two-membrane traversal problem with low probability.
Gut dysbiosis leads to LPS translocation, triggering intestinal and systemic inflammation via TLR4/MyD88/NF-κB signaling, promoting α-synuclein pathology. The peripheral gut barrier is the most viable intervention point, though CNS microglial TLR4 activation remains mechanistically tenuous. Best therapeutic approach: zonulin antagonists (larazotide) for gut barrier restoration combined with NLRP3 inflammasome inhibition rather than direct TLR4 blockade.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
TREM2-independent neuronal protection vi
11/11
dimensions won
LPS-TLR4-NF-κB Signaling Cascade as Ther
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.32
0.82
Evidence
0.35
0.58
Novelty
0.50
0.55
Feasibility
0.30
0.70
Impact
0.40
0.75
Druggability
0.25
0.70
Safety
0.60
0.68
Competition
0.70
0.75
Data
0.35
0.55
Reproducible
0.30
0.52
KG Connect
0.50
0.50
Score Breakdown
Dimension
TREM2-independent neuronal pro
LPS-TLR4-NF-κB Signaling Casca
Mechanistic
0.320
0.820
Evidence
0.350
0.580
Novelty
0.500
0.550
Feasibility
0.300
0.700
Impact
0.400
0.750
Druggability
0.250
0.700
Safety
0.600
0.680
Competition
0.700
0.750
Data
0.350
0.550
Reproducible
0.300
0.520
KG Connect
0.500
0.500
Evidence
TREM2-independent neuronal protection via cystatin-C/LRP2 si
No evidence citations yet
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target
No evidence citations yet
Debate Excerpts
TREM2-independent neuronal protection via cystatin
# Critical Evaluation of Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid
## Preliminary Methodological Concerns
Before evaluating individual hypotheses, several systemic issues constrain ...
Domain Expert
The key feasibility filter is the source paper itself. In the February 5, 2026 `Cell` paper, Li et al. report that peripheral cancer/CSPs reduced amyloid in `5xFAD` and `APP/PS1`, but “did not affect ...
Synthesizer
{"ranked_hypotheses":[{"title":"Anti-inflammatory microglial reprogramming via cystatin-C/TREM2 axis","description":"Systemic tumors secrete cystatin C which crosses the BBB via LRP1 and engages TREM2...
LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Ta
4 rounds · quality: 1.00
Theorist
# Mechanistic Hypotheses: Gut-Brain Axis in Parkinson's Disease
---
## Hypothesis 1: LPS-Induced TLR4/NF-κB Signaling Cascade Drives α-Synuclein Pathology
**Proposed Mechanism:**
Gut dysbiosis in P...
Skeptic
# Critical Evaluation of Gut-Brain Axis Hypotheses in Parkinson's Disease
## Overarching Methodological Concerns (Applicable to All Hypotheses)
Before examining individual hypotheses, several fundam...
Domain Expert
# Gut-Brain Axis in Parkinson's Disease: Therapeutic Development Assessment
## Executive Summary
Of the four mechanistic hypotheses proposed, none survives the skeptic's critique unscathed. However,...
Synthesizer
{"ranked_hypotheses":[{"title":"LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target","description":"Gut dysbiosis leads to LPS translocation, triggering intestinal and systemic inflammation via TLR...